Mustang Bio, Inc. (MBIO) Social Stream



Mustang Bio, Inc. (MBIO): $0.74

0.02 (+3.24%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add MBIO to Watchlist
Sign Up

Industry: Biotech


Ranked

of 402

in industry

Mustang Bio Inc (MBIO) Price Targets From Analysts

Use the tables below to see what analysts covering Mustang Bio Inc think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-08-18 3 $13 $7 $10.4 $1.04 900%
2021-11-15 4 $13 $7 $10.4 $1.04 900%
2021-12-17 5 $13 $7 $9.8 $1.04 842.31%
2022-02-18 5 $11 $6 $8.4 $1.04 707.69%
2022-03-24 5 $11 $6 $8 $1.04 669.23%

The Trend in the Analyst Price Target


MBIO's average price target has moved down $1 over the prior 23 months.

Over the past 50 weeks, MBIO's average upside potential has been 298.88%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-04-25 1 13 7 10.25 3.15 225.4%
2021-05-08 1 13 7 10.25 3.05 236.07%
2021-08-28 3 13 7 10.40 3.02 244.37%
2021-09-04 3 13 7 10.40 2.98 248.99%
2022-01-24 5 11 6 8.40 1.30 546.15%

MBIO Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 5 0 0 0 0 5

The Trend in the Broker Recommendations


MBIO's average broker recommendation rating improved by 0 over the prior 16 months.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for MBIO as an investment opportunity.

  • To contextualize these metrics, consider that out of all US stocks, Mustang Bio Inc's upside potential (average analyst target price relative to current price) is greater than 491.2% of them.
  • To contextualize these metrics, consider that out of all US stocks, Mustang Bio Inc's average analyst price target is greater than 40.56% of them.
  • In the context of stocks in the small market cap category, Mustang Bio Inc's variance in analysts' estimates is lower than -266.34% of them.
  • To contextualize these metrics, consider that out of Healthcare stocks, Mustang Bio Inc's number of analysts covering the stock is higher than 145.31% of them.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to Mustang Bio Inc are MACK, LXRX, and LVTX.

Is MBIO a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.6562 seconds.